← ANALYST RATINGS · TIPRANKS
McKesson (MCK): analyst forecast and price target
Analyst consensus
Strong Buy10 Buy2 Hold0 Sell
Ratings of 12 analysts in the last 3 months · top analysts only12-month forecast
Based on 12 price targets given in the last 3 months, the average target is $998, the highest $1,200, the lowest $845. The average is −0.7% from the last price of $1,005.
Analyst ratings 16
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $1,080 → $1,200+11.1% | Buy | +19.4% | Reiterated | 16.10.26on TipRanks 07:55 | +1.7% | ↗ |
| Unknown Analyst | Leerink Partners | $1,030 → $1,070+3.9% | Buy | +6.5% | Reiterated | 07.10.26on TipRanks Oct 14 21:01 | −1.0%next day +2.6% · 5 days +8.3% | ↗ |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $845 | Hold | −15.9% | Reiterated | 06.10.26on TipRanks 21:45 | −1.0%next day +2.6% · 5 days +8.3% | ↗ |
| AI xAi Medical - DistributionxAI Grok-3 | TipRanks - xAI | $993 → $1,030+3.7% | Buy | +2.5% | Reiterated | 06.10.26on TipRanks 16:05 | — | |
| AI DeepSeek Medical - DistributionDeepSeek R1-0528 | TipRanks - DeepSeek | $997 → $1,025+2.8% | Buy | +2.0% | Reiterated | 06.10.26on TipRanks 16:05 | — | |
| AI OpenAI Medical - DistributionOpenAI 4o | TipRanks - OpenAI | $988 → $1,012+2.4% | Buy | +0.7% | Reiterated | 06.10.26on TipRanks 16:05 | — | |
| AI Anthropic Medical - DistributionAnthropic Opus-4.1 | TipRanks - Anthropic | $988 → $1,009+2.1% | Buy | +0.4% | Reiterated | 06.10.26on TipRanks 16:05 | — | |
| AI Google Medical - DistributionGemini 2.5Pro | TipRanks - Google | $1,006 → $1,044+3.8% | Buy | +3.9% | Reiterated | 06.10.26on TipRanks 16:05 | — | |
| AI PerPlexity Medical - DistributionPerPlexity SonarPro | TipRanks - PerPlexity | $1,029 → $1,053+2.3% | Buy | +4.8% | Reiterated | 06.10.26on TipRanks 16:05 | — | |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $1,000 | Buy | −0.5% | Reiterated | 06.10.26on TipRanks 09:25 | +0.1%next day −1.0% · 5 days +4.5% | ↗ |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | $913 | Buy | −9.1% | Reiterated | 06.10.26on TipRanks 09:10 | +0.1%next day −1.0% · 5 days +4.5% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $977 | Buy | −2.8% | Reiterated | 06.10.26on TipRanks 06:55 | +0.1%next day −1.0% · 5 days +4.5% | ↗ |
| Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% | Bank of America Securities | $1,050 | Buy | +4.5% | Reiterated | 05.10.26on TipRanks Oct 6 06:35 | +0.8%next day +0.1% · 5 days +4.0% | ↗ |
| Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% | William Blair | — | Buy | — | Reiterated | 05.10.26on TipRanks 18:15 | +0.1%next day −1.0% · 5 days +4.5% | ↗ |
| Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% | Barclays | $925 → $1,000+8.1% | Buy | −0.5% | Reiterated | 18.08.26on TipRanks Aug 19 03:11 | +1.8%next day −2.0% · 5 days +4.3% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $812 → $933+14.9% | Hold | −7.1% | Assigned | 11.08.26on TipRanks 06:55 | +2.8%next day −2.8% · 5 days −3.2% | ↗ |
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | $1,042 | Buy | +3.7% | Reiterated | 10.08.26on TipRanks Aug 11 08:05 | +1.2%next day +2.8% · 5 days −2.2% | ↗ |
| Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% | Citi | $1,000 | Buy | −0.5% | Reiterated | 10.08.26on TipRanks 16:30 | +2.8%next day −2.8% · 5 days −3.2% | ↗ |
| Eric Coldwell★★★★★★★★★★#1091 · hits 59% · avg +7.7% | Robert W. Baird | $955 → $1,015+6.3% | Buy | +1.0% | Reiterated | 06.08.26on TipRanks 09:30 | −0.5%next day −0.8% · 5 days −2.9% | ↗ |
| Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% | TD Cowen | $989 → $1,006+1.7% | Buy | +0.1% | Assigned | 06.08.26on TipRanks Aug 5 22:38 | −0.5%next day −0.8% · 5 days −2.9% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $885 → $905+2.3% | Hold | −9.9% | Reiterated | 05.08.26on TipRanks Aug 6 07:25 | +5.8%next day −0.5% · 5 days −0.2% | ↗ |
| Unknown Analyst | William O'Neil | — | Buy | — | Initiated | 17.10.25on TipRanks Oct 18 08:50 | +0.8%next day −0.8% · 5 days +0.1% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering McKesson
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $988 at a price of $854 (+15.7%); now: $997 at $1,005 (−0.8%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 20 | 22 | 21 | 22 | 21 | 23 |
| Hold | 4 | 3 | 1 | 2 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 04.11.26 (Q2 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $10.72 (from $10.53 to $10.91). Last quarter: $9.93.
Sales
Next quarter’s sales estimate — $109.9B (from $108.8B to $110.8B). Last quarter: $105.4B.
Best top-analyst consensus in the sector · Healthcare
About McKesson
- CEO: Brian S. Tyler
- Employees: 42,300
- 6555 State Highway 161, Irving, TX, 75039, US
- www.mckesson.com
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Data from the stock’s TipRanks forecast page, read 53 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗